Register now!

Pharmaceutical Industry

Is the
current model fit for purpose?

These are symptoms of a decline of the pre-digital era model of medicinal product development. Our pharmaceutical industry members are those who are committed to moderninsing their product development to create safer and more effective medicinal products. 

Modernisation of the pharmaceutical industry requires a coresponding moderninsation of the way in which medicinal products are brought on to the market and the design of clinical trials. The Avicenna Alliance is working to promote modelling and simulation as a means of addressing the high cost of research and the uptake of in silico methods.

Avicenna Alliance news

And the EMA goes to… Amsterdam!

During a General Affairs Council meeting on 20 November, the EU27 ministers decided on the new location of the European Medicines Agency (EMA) and the European Banking...

find out more ›

Commission adopts 2018 Work Programme

Following on from the announcements made in President Juncker's 2017 State of the Union Address, the European Commission adopted on 24 October 2017 its 2018 Work...

find out more ›

Avicenna Alliance interview for ANSYS

For the Avicenna Alliance, in silico medicine is the obvious connect between the promise of big data and the need for personalised medicine. In an interview for...

find out more ›

Show all activites